Amneal Pharmaceuticals, Inc.
AMRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3,144,822 | $2,538,149 | $2,606,633 | $2,454,012 |
| - Cash | $201,249 | $81,186 | $59,187 | $110,552 |
| + Debt | $2,685,724 | $2,581,893 | $2,579,501 | $2,593,139 |
| Enterprise Value | $5,629,297 | $5,038,856 | $5,126,947 | $4,936,599 |
| Revenue | $784,513 | $724,508 | $695,420 | $730,518 |
| % Growth | 8.3% | 4.2% | -4.8% | – |
| Gross Profit | $273,974 | $286,253 | $255,891 | $262,873 |
| % Margin | 34.9% | 39.5% | 36.8% | 36% |
| EBITDA | $111,664 | $176,925 | $154,584 | $112,473 |
| % Margin | 14.2% | 24.4% | 22.2% | 15.4% |
| Net Income | $2,369 | $22,417 | $12,195 | -$31,081 |
| % Margin | 0.3% | 3.1% | 1.8% | -4.3% |
| EPS Diluted | 0.008 | 0.07 | 0.038 | -0.1 |
| % Growth | -89.2% | 84.8% | 137.6% | – |
| Operating Cash Flow | $118,450 | $83,819 | $7,408 | $118,078 |
| Capital Expenditures | -$15,050 | -$26,502 | -$18,322 | -$23,064 |
| Free Cash Flow | $103,400 | $57,317 | -$10,914 | $95,014 |